Pharmaceutical patent term extensions: broader is not always better

Ono Pharmaceutical Co., Ltd. et al [2020] APO 43 (16 September 2020) Background Australia’s Patents Act provides a patent term extension (PTE) to account for the delays that can occur when obtaining regulatory approval for a pharmaceutical substance.   The extension can last for up to five years and is available when the following requirements are